ROYAL BANK OF CANADA - PROCESSA PHARMACEUTICALS INC ownership

PROCESSA PHARMACEUTICALS INC's ticker is PCSA and the CUSIP is 74275C205. A total of 23 filers reported holding PROCESSA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PROCESSA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,00046,382
+30616.6%
0.00%
Q2 2023$0
-100.0%
151
-84.9%
0.00%
Q4 2022$1,000
-50.0%
1,000
-1.5%
0.00%
Q3 2022$2,000
-33.3%
1,015
+1.5%
0.00%
Q2 2022$3,0000.0%1,0000.0%0.00%
Q1 2022$3,000
-40.0%
1,0000.0%0.00%
Q4 2021$5,0001,0000.00%
Other shareholders
PROCESSA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Coastal Bridge Advisors, LLC 52,500$13,1360.00%
Mirador Capital Partners LP 19,516$4,8830.00%
WELLS FARGO & COMPANY/MN 3,238$8100.00%
NORTHERN TRUST CORP 15,401$3,8530.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 152,670$38,9300.00%
STATE STREET CORP 42,786$10,9100.00%
MILLENNIUM MANAGEMENT LLC 25,930$6,6120.00%
BlackRock Inc. 293$730.00%
Citadel Advisors 166,224$42,3870.00%
View complete list of PROCESSA PHARMACEUTICALS INC shareholders